Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.
Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W. Gulley JL, et al. Among authors: beetham p. Clin Cancer Res. 2005 May 1;11(9):3353-62. doi: 10.1158/1078-0432.CCR-04-2062. Clin Cancer Res. 2005. PMID: 15867235 Clinical Trial.
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
Arlen PM, Gulley JL, Parker C, Skarupa L, Pazdur M, Panicali D, Beetham P, Tsang KY, Grosenbach DW, Feldman J, Steinberg SM, Jones E, Chen C, Marte J, Schlom J, Dahut W. Arlen PM, et al. Among authors: beetham p. Clin Cancer Res. 2006 Feb 15;12(4):1260-9. doi: 10.1158/1078-0432.CCR-05-2059. Clin Cancer Res. 2006. PMID: 16489082 Free PMC article. Clinical Trial.
Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas.
Marshall JL, Gulley JL, Arlen PM, Beetham PK, Tsang KY, Slack R, Hodge JW, Doren S, Grosenbach DW, Hwang J, Fox E, Odogwu L, Park S, Panicali D, Schlom J. Marshall JL, et al. Among authors: beetham pk. J Clin Oncol. 2005 Feb 1;23(4):720-31. doi: 10.1200/JCO.2005.10.206. Epub 2004 Dec 21. J Clin Oncol. 2005. PMID: 15613691 Clinical Trial.
Clinical trial registration was not an indicator for low risk of bias.
Farquhar CM, Showell MG, Showell EAE, Beetham P, Baak N, Mourad S, Jordan VMB. Farquhar CM, et al. Among authors: beetham p. J Clin Epidemiol. 2017 Apr;84:47-53. doi: 10.1016/j.jclinepi.2016.11.011. Epub 2017 Jan 11. J Clin Epidemiol. 2017. PMID: 28088595 Review.
Oligonucleotide-Mediated Genome Editing Provides Precision and Function to Engineered Nucleases and Antibiotics in Plants.
Sauer NJ, Narváez-Vásquez J, Mozoruk J, Miller RB, Warburg ZJ, Woodward MJ, Mihiret YA, Lincoln TA, Segami RE, Sanders SL, Walker KA, Beetham PR, Schöpke CR, Gocal GF. Sauer NJ, et al. Among authors: beetham pr. Plant Physiol. 2016 Apr;170(4):1917-28. doi: 10.1104/pp.15.01696. Epub 2016 Feb 10. Plant Physiol. 2016. PMID: 26864017 Free PMC article.
Oligonucleotide-directed mutagenesis for precision gene editing.
Sauer NJ, Mozoruk J, Miller RB, Warburg ZJ, Walker KA, Beetham PR, Schöpke CR, Gocal GF. Sauer NJ, et al. Among authors: beetham pr. Plant Biotechnol J. 2016 Feb;14(2):496-502. doi: 10.1111/pbi.12496. Epub 2015 Oct 27. Plant Biotechnol J. 2016. PMID: 26503400 Free PMC article. Review.
24 results